A growing library of true market leaders, studied chart by chart. Each entry takes a real setup — an event, a cohort, or a single name — and asks what worked, what was learnable, and what is repeatable.
New entries land on a weekly rhythm. Every one is process-focused and intended for study — never as a recommendation to act.
15 leaders tracked since the April 8, 2026 follow-through day. Why buying at and near new highs — counter to instinct — was the right call, with the cohort that proved it.
A clean small-base breakout ran +50% and gave it all back in a semiconductor exhaustion. The Fault-Line Protocol (House Rule 01) was born here — the rule that makes this trade structurally impossible to repeat.
An episodic pivot: Moderna gapped ∼+177% on an mRNA cancer-vaccine Phase 3 win that re-rated it from fading COVID play to AI-enabled personalized-oncology platform. The AI backbone, the tech-stack read, catalyst cousins like TEM, and why risk management is the whole trade.
The Model Book holds three flavors of case study, all anchored to real markets and real rules.
A group of names tied to a single event — a follow-through day, a sector rotation, a macro pivot — tracked side by side so the pattern is visible across the group.
One stock studied chart by chart through its biggest move — the base, the pivot, the breakout, the manage. The shape of a monster as it unfolded.
One highlighted chart a week on the hardest skill in trading: managing a monster winner without giving the gain back. The lesson is in the management, not the entry.
